Hormone therapy is primarily used in cancers that are sensitive to hormones, such as breast and prostate cancers. These cancers are hormone receptor-positive, meaning they have receptors on their surface that respond to hormones. Both hormone therapy and immunotherapy have revolutionized cancer treatment, offering more targeted and personalized options. Treatment decisions are made based on the specific characteristics of the cancer, the presence of certain biomarkers, and individual patient considerations. Close collaboration between patients and their healthcare teams is crucial to determining the most effective and well-tolerated treatment plan.